Global Digital Biomarkers Market Size, Trends, Growth Analysis and Forecast by 2028

Comments · 76 Views

The growing incidence of chronic diseases is one of the significant factors influencing the market growth.

Digital Biomarkers market size is projected to be worth USD 10.38 Billion by 2027, according to a current analysis by Emergen Research.

 

The report is primarily targeted at the Digital Biomarkers industry participants and stakeholders that can capitalize on the contents of this report and make informed business decisions during the forecast period.

 

The growing incidence of chronic diseases is one of the significant factors influencing the market growth.

According to the statics released by WHO (World Health Organization), the burden of chronic diseases is projected to grow by 57.0% by the year 2020 from 2001. Developing nations are expected to be highly impacted, contributing to 60.0% of the global burden of chronic diseases.

The market size estimation and forecasts have been detailed in this report. The authors have studied the historical background of the Digital Biomarkers market, keeping in mind the organic and inorganic growth prospects and threats for the market. Thus, the latest report offers precise estimates of the global market size for the forecast period.

 

Request a sample copy of this report @ https://www.emergenresearch.com/request-sample/360

 

Some Key Highlights From the Report

  • In September 2020, Koneksa, a firm engaged in the development and implementation of patient-specific digital biomarkers for use in the drug development process, declared the completion of Series B funding round worth USD 16.0 Million. Koneska intends to deploy the fund for the integration of wearables and other patient-specific technologies into clinical research by expanding its digital platform.
  • The low cost and improved scalability of digital biomarkers based on smartphone apps help in facilitating a prospective wealth of social, behavioral, psychological, and environmental data that were formerly inaccessible.
  • Recent psychiatric assessment approaches are resource-intensive and consume substantial time for evaluation. Digital biomarkers development is considered to hod immense prospects in allowing time-sensitive, scalable, and affordable assessment of symptom changes and psychiatric diagnosis.

 

Browse Detailed Analysis of this Research Report@ https://www.emergenresearch.com/industry-report/digital-biomarkers-market

 

Emergen Research has segmented the global digital biomarkers market on the basis of system component, therapeutic area, end-users, and region:

  • System Component Outlook (Revenue, USD Billion; 2017-2027)
    • Data Collection Tools
      1. Digital Platforms
      2. Mobile Apps
      3. Desktop-Based Software
      4. Wearable
      5. Biosensors
    • Data Integration Systems
  • Therapeutic Area Outlook (Revenue, USD Billion; 2017-2027)
    • Cardiovascular Disease
    • Sleep and Movement Disease
    • Neurodegenerative Disorders
    • Psychiatric Disorder
    • Gastrointestinal Disease
    • Respiratory Disease
    • Diabetes
    • Others
  • End-Users Outlook (Revenue, USD Billion; 2017-2027)
    • Pharmaceutical Companies
    • Providers
    • Payers

Major Companies Listed

  • AliveCor Inc.
  • Bayer AG
  • Evidation Health Inc.
  • Fitbit Inc.
  • Happify Health
  • Koninklijke Philips NV
  • Neurotrack Technologies Inc.
  • GlaxoSmithKline Inc.
  • Novartis International AG
  • Hoffmann-La Roche Ltd.

Get Instant Discount on this Report @ https://www.emergenresearch.com/request-discount/360

Geographical Backdrop:

North America held a significant digital biomarker market share in 2091 attributed to the high penetration of smartphones and wearable devices, along with the growing prevalence of lifestyle-related diseases, which, in turn, persuades consumers to monitor their vital signs for a better insight into health conditions.

The global Digital Biomarkers market has been categorized into several important geographical regions, including North America, Europe, Asia Pacific, Latin America, and Middle East Africa. In this section, authors of the report have studied the presence of the global Digital Biomarkers market across major geographies. Moreover, the estimated market share, market size, revenue contribution, sales network and distribution channel, and other crucial elements of each regional segment have been detailed in the report.

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/360

Thank you for reading our report. For further information regarding the report or to get a customized copy of it, please connect with us. We will make sure you receive a report perfectly tailored to your needs.

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:                   

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Comments